[12] Patent
[11] Patent No.:GC0011503  
[45] Date of Publishing the Grant of the Patent: 30/Nov /2020                76/2020  
Number of the Decision to Grant the Patent:2020/175507
Date of the Decision to Grant the Patent:24/Nov/2020

[21] Application No.:GC 2012-20318

[22] Filing Date:23/1/2012

[30] Priority:

[33] State [32] Priority date [31] Priority No.
EP
24/1/2011
111518766

[72] Inventors:1- Ralf ANDERSKEWITZ،2- Domnic MARTYRES،3- Thorsten OOST،4- Wolfgang RIST،5- Peter SEITHER

[73] Owner: GB007, Inc., 3013Science Park Road, Suite 200, San Diego, CA 92121, USA, San Diego, USA

[74] Agent: Saba & Co. T.M.P

  

 

  

[51]IPC:

[56] Cited Documents:

-WO 2010/057118 A2 (AMIRA PHARMACEUTICALS
INC [US] ; HUTCHINSON JOHN HOWARD [US] ;
STOCK NIC) 20 May 2010
 
Examiner: PH. Mohammad S. AlMousa

[54] PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS
[57] Abstract: PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTSABSTRACTThe present invention relates to pyrazole compounds of formula (Ia) or (Ib) and pharmaceutically acceptable salts thereof,
No. of claims: 82


 

Note: Any interested individual may, within 3 months of publication of the grant, file objection thereof with the Grievance Committee after payment of grievance fees.